应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
FLGT Fulgent Genetics Inc.
未开盘 04-27 16:00:00 EDT
15.60
-0.71
-4.35%
盘后
15.60
+0.00
0.00%
18:30 EDT
最高
16.50
最低
15.59
成交量
45.59万
今开
16.22
昨收
16.31
日振幅
5.61%
总市值
4.50亿
流通市值
2.84亿
总股本
2,884万
成交额
722.08万
换手率
2.51%
流通股本
1,817万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Fulgent Genetics, Inc.盘中异动 早盘急速下跌7.66%
市场透视 · 03-02
Fulgent Genetics, Inc.盘中异动 早盘急速下跌7.66%
Fulgent Genetics, Inc.股价重挫26.01% 市值跌1.47亿美元
市场透视 · 02-27
Fulgent Genetics, Inc.股价重挫26.01% 市值跌1.47亿美元
Fulgent Genetics, Inc.盘中异动 早盘股价大涨5.27%
市场透视 · 01-07
Fulgent Genetics, Inc.盘中异动 早盘股价大涨5.27%
Fulgent Genetics第三季度收入为8406.9万美元
投资观察 · 2025-11-20
Fulgent Genetics第三季度收入为8406.9万美元
Fulgent Genetics, Inc.盘中异动 股价大涨5.04%
市场透视 · 2025-11-11
Fulgent Genetics, Inc.盘中异动 股价大涨5.04%
异动解读 | Fulgent Genetics盘中大涨19.81%，上调全年营收预期且三季度业绩超预期
异动解读 · 2025-11-07
异动解读 | Fulgent Genetics盘中大涨19.81%，上调全年营收预期且三季度业绩超预期
异动解读 | 富尔金特基因公司盘前大涨9.20%，上调全年营收预期且三季度业绩超预期
异动解读 · 2025-11-07
异动解读 | 富尔金特基因公司盘前大涨9.20%，上调全年营收预期且三季度业绩超预期
加载更多
公司概况
公司名称：
Fulgent Genetics Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Fulgent Genetics, Inc.在2016年5月13日注册成立于美国特拉华州。该公司是一家以技术为基础的公司，拥有成熟的临床诊断业务和治疗开发业务。该公司临床诊断业务提供分子诊断检测服务、全面的基因检测和高质量的解剖病理实验室服务，旨在为医生和患者提供临床可操作的诊断信息，以提高患者护理质量。该公司的治疗开发业务专注于使用新型纳米封装和靶向治疗平台开发治疗多种癌症的候选药物，该平台旨在改善新的和现有癌症药物的治疗窗口和药代动力学特征，或PK特征。该公司的目标是从基因组诊断业务转型为一家完全整合的精准医疗公司。
发行价格：
--
{"stockData":{"symbol":"FLGT","market":"US","secType":"STK","nameCN":"Fulgent Genetics Inc.","latestPrice":15.6,"timestamp":1777320000000,"preClose":16.31,"halted":0,"volume":455907,"hourTrading":{"tag":"盘后","latestPrice":15.6,"preClose":15.6,"latestTime":"18:30 EDT","volume":9632,"amount":150269.2,"timestamp":1777329050829,"change":0,"changeRate":0,"amplitude":0.000641},"delay":0,"changeRate":-0.04353157572041687,"floatShares":18174500,"shares":28844600,"eps":-1.97,"marketStatus":"未开盘","change":-0.71,"latestTime":"04-27 16:00:00 EDT","open":16.22,"high":16.5,"low":15.585,"amount":7220808.250752,"amplitude":0.056101,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.97,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777363200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1475121600000,"exchange":"NASDAQ","adjPreClose":16.31,"postHourTrading":{"tag":"盘后","latestPrice":15.6,"preClose":15.6,"latestTime":"18:30 EDT","volume":9632,"amount":150269.2,"timestamp":1777329050829,"change":0,"changeRate":0,"amplitude":0.000641},"volumeRatio":1.374686,"impliedVol":0.7424,"impliedVolPercentile":0.9681},"requestUrl":"/m/hq/s/FLGT","defaultTab":"news","newsList":[{"id":"2616356484","title":"Fulgent Genetics, Inc.盘中异动 早盘急速下跌7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616356484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616356484?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:41","pubTimestamp":1772462500,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时41分，Fulgent Genetics, Inc.股票出现波动，股价急速下跌7.66%。Fulgent Genetics, Inc.股票所在的生命科学行业中，整体跌幅为1.59%。其相关个股中，Genedx Holdings Corp C/Wts 22/07/2026 、Xwell, Inc.、万基遗传涨幅较大，Xwell, Inc.、Endra Life Sciences Inc.、Personalis, Inc.较为活跃，换手率分别为35.40%、1.76%、0.66%，振幅较大的相关个股有Xwell, Inc.、Personalis, Inc.、Biodesix, Inc.，振幅分别为22.15%、12.58%、10.50%。Fulgent Genetics, Inc.公司简介：Fulgent Genetics Inc 是一家专注于基因检测的技术公司，为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302224141a4429462&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302224141a4429462&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGT","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614245894","title":"Fulgent Genetics, Inc.股价重挫26.01% 市值跌1.47亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614245894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614245894?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:31","pubTimestamp":1772202713,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日22时31分，Fulgent Genetics, Inc.股票出现波动，股价快速下挫26.01%。Fulgent Genetics, Inc.股票所在的生命科学行业中，整体跌幅为1.07%。其相关个股中，Xwell, Inc.、Biodesix, Inc.、因美纳涨幅较大，Xwell, Inc.、Endra Life Sciences Inc.、Biodesix, Inc.较为活跃，换手率分别为196.55%、0.88%、0.35%，振幅较大的相关个股有Xwell, Inc.、Biodesix, Inc.、Castle Biosciences, Inc.，振幅分别为11.03%、9.07%、6.84%。Fulgent Genetics, Inc.公司简介：Fulgent Genetics Inc 是一家专注于基因检测的技术公司，为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227223153a437c08d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227223153a437c08d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGT","BDSX","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601332509","title":"Fulgent Genetics, Inc.盘中异动 早盘股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601332509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601332509?lang=zh_cn&edition=full","pubTime":"2026-01-07 23:16","pubTimestamp":1767798975,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日23时16分，Fulgent Genetics, Inc.股票出现波动，股价快速拉升5.27%。Fulgent Genetics, Inc.股票所在的生命科学行业中，整体涨幅为0.18%。其相关个股中，Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies, Inc.、燃石医学涨幅较大，Mainz Biomed N.V.、Bioaffinity Technologies, Inc.、Ispecimen Inc.较为活跃，换手率分别为2.50%、1.35%、1.19%，振幅较大的相关个股有Mainz Biomed N.V.、Bioaffinity Technologies, Inc.、燃石医学，振幅分别为12.59%、12.40%、9.31%。Fulgent Genetics, Inc.公司简介：Fulgent Genetics Inc 是一家专注于基因检测的技术公司，为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107231615a4a851b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107231615a4a851b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","FLGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154327299","title":"Fulgent Genetics第三季度收入为8406.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154327299","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154327299?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:10","pubTimestamp":1763572212,"startTime":"0","endTime":"0","summary":"11月7日报道 - Fulgent Genetics第三季度营业收入为-1535万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLGT","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582348385","title":"Fulgent Genetics, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582348385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582348385?lang=zh_cn&edition=full","pubTime":"2025-11-11 23:20","pubTimestamp":1762874408,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日23时20分，Fulgent Genetics, Inc.股票出现异动，股价快速拉升5.04%。Fulgent Genetics, Inc.股票所在的生命科学行业中，整体涨幅为1.19%。Fulgent Genetics, Inc.公司简介：Fulgent Genetics Inc 是一家专注于基因检测的技术公司，为医生提供临床可操作的诊断信息。消息层面，截至23时20分，《派杰投资维持Fulgent Genetics持有评级，上调目标价至30美元》资讯为影响Fulgent Genetics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111232008a6f24fb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111232008a6f24fb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGT","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188364264","title":"异动解读 | Fulgent Genetics盘中大涨19.81%，上调全年营收预期且三季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1188364264","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188364264?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:48","pubTimestamp":1762526908,"startTime":"0","endTime":"0","summary":"基因检测公司Fulgent Genetics今日盘中大涨19.81%，引发市场广泛关注。该公司股价的强劲表现主要源于其最新发布的财务预期调整和亮眼的季度业绩报告。富尔金特基因宣布上调2025财年的营收预期至3.25亿美元，高于此前预期的3.2亿美元。值得注意的是，富尔金特基因的股价在此次上涨前已经累计上涨20.8%。此次盘中大涨进一步凸显了市场对公司未来发展前景的乐观态度。随着基因检测技术在医疗健康领域的应用不断扩大，富尔金特基因有望继续受益于行业增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["FLGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186239035","title":"异动解读 | 富尔金特基因公司盘前大涨9.20%，上调全年营收预期且三季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1186239035","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186239035?lang=zh_cn&edition=full","pubTime":"2025-11-07 21:34","pubTimestamp":1762522463,"startTime":"0","endTime":"0","summary":"基因检测公司富尔金特基因今日盘前大涨9.20%，引发市场关注。该公司股价的强劲表现主要源于其最新发布的财务预期和季度业绩报告。富尔金特基因宣布上调2025财年的营收预期至3.25亿美元，高于此前预期的3.2亿美元。同时，公司公布的第三季度营收为8407万美元，远超市场预期的8140万美元。值得注意的是，富尔金特基因的股价在此次上涨前已经累计上涨20.8%。随着基因检测技术在医疗健康领域的应用不断扩大，富尔金特基因有望继续受益于行业增长。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["FLGT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fulgentgenetics.com","stockEarnings":[{"period":"1week","weight":-0.0358},{"period":"1month","weight":0.0006},{"period":"3month","weight":-0.4279},{"period":"6month","weight":-0.3137},{"period":"1year","weight":-0.1737},{"period":"ytd","weight":-0.4062}],"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.1279},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2988},{"period":"ytd","weight":0.0488}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fulgent Genetics, Inc.在2016年5月13日注册成立于美国特拉华州。该公司是一家以技术为基础的公司，拥有成熟的临床诊断业务和治疗开发业务。该公司临床诊断业务提供分子诊断检测服务、全面的基因检测和高质量的解剖病理实验室服务，旨在为医生和患者提供临床可操作的诊断信息，以提高患者护理质量。该公司的治疗开发业务专注于使用新型纳米封装和靶向治疗平台开发治疗多种癌症的候选药物，该平台旨在改善新的和现有癌症药物的治疗窗口和药代动力学特征，或PK特征。该公司的目标是从基因组诊断业务转型为一家完全整合的精准医疗公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.108175},{"month":2,"riseRate":0.3,"avgChangeRate":-0.052634},{"month":3,"riseRate":0.4,"avgChangeRate":-0.015487},{"month":4,"riseRate":0.3,"avgChangeRate":0.016214},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.000322},{"month":6,"riseRate":0.555556,"avgChangeRate":0.030965},{"month":7,"riseRate":0.666667,"avgChangeRate":0.112027},{"month":8,"riseRate":0.333333,"avgChangeRate":0.040364},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.027123},{"month":10,"riseRate":0.1,"avgChangeRate":-0.072376},{"month":11,"riseRate":0.6,"avgChangeRate":0.096806},{"month":12,"riseRate":0.7,"avgChangeRate":0.038713}],"exchange":"NASDAQ","name":"Fulgent Genetics Inc.","nameEN":"Fulgent Genetics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fulgent Genetics Inc.,FLGT,Fulgent Genetics Inc.股票,Fulgent Genetics Inc.股票老虎,Fulgent Genetics Inc.股票老虎国际,Fulgent Genetics Inc.行情,Fulgent Genetics Inc.股票行情,Fulgent Genetics Inc.股价,Fulgent Genetics Inc.股市,Fulgent Genetics Inc.股票价格,Fulgent Genetics Inc.股票交易,Fulgent Genetics Inc.股票购买,Fulgent Genetics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}